Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.735 USD | +1.09% | -8.92% | +28.95% |
05-23 | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
05-14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |